Author | Michael A. Caligiuri, MD | OncLive

Author | Michael A. Caligiuri, MD

Articles

Dr. Caligiuri on the Anti-KIR Antibody IPH2101

December 19, 2013

Video

Michael A. Caligiuri, MD, CEO, The James Cancer Hospital Solove Research Institute, director, Comprehensive Cancer Center, Ohio State University, discusses the anti-KIR antibody IPH2101 in myeloma and leukemia.

x